With the recreational market set for legalization on July 1, 2018, Canada’s cannabis industry is experiencing a high that is catalyzing innovation in the biosciences sector. Pioneering biopharmaceutical companies there and in other developed countries are working to develop a variety of healthful products based on their research into cannabinoids. As a result, investment capital flow to “plant-to-bloodstream” companies is expected to swell just as it has been doing for “seed-to-plant” companies for some time, and innovative British Columbia-based outfit Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) will, undoubtedly, be buoyed by this development, since it is a “first mover” in this space.

Lexaria is one of that new breed of “plant-to-bloodstream” companies exploring ways to make the health benefits of cannabinoids more accessible. The company has developed technology that delivers the nutriments of hemp oil in a novel and more effective way. Many hemp products on the market are simply mixtures of hemp oil with other ingredients. However, Lexaria’s patented methodology infuses organically sourced hemp oil into the molecules of other substances, such as lipids, which, as it turns out, form the basis of the human endocannabinoid system. Consequently, the body better absorbs products employing the technology.

In general, the human gastrointestinal tract does not handle cannabinoids effectively, and much of what is ingested is simply excreted by the body. In addition, realizing this, many users of edible products will try other cannabinoid delivery methods, such as smoking, with their attendant evils. For those smoking cannabis, there is more peril in the smoking than in the cannabis.

Lexaria applies its innovative delivery technology to its product line, which consists of two distinct brands: ViPova™ and Lexaria Energy. ViPova™ is a delicious Chinese black tea from the province of Yunnan, made from hemp oil-infused within dried evaporated non-fat milk. Introduced in January 2015, the tea is available in a host of varieties and flavors. The ViPova range runs from 8- to 32-bag portions, and varieties include Decaf English Breakfast, Earl Grey, Herbal Bengal Chai, Herbal Cherry Black Tea, Herbal Masala Chai, Low-Caf Organic Evening Green Tea and ViPova Light.

If you are a couch potato, Lexaria Energy products are not for you. The Lexaria Energy line is meant for those with busy, active lifestyles. Under this brand, the company has launched a hemp oil-infused protein bar called the Lexaria Energy Bar, which, as its name suggests, provides reserves of energy you can draw on to go the extra mile.

Lexaria is not resting on its laurels with these groundbreaking developments. In February 2017, it signed a master collaborative research agreement with the National Research Council of Canada (NRC) to investigate technical aspects and new opportunities associated with bioavailability enhancement of lipophilic active ingredient compositions. Lexaria believes its patented technology can be applied to the delivery of nicotine, vitamins, analgesics and a variety of other substances.

In May 2017, the company announced that its 50%-owned joint venture subsidiary, Ambarii Trade Corporation (Ambarii) had entered into a Letter-of-Intent (LOI) with Naturally Splendid Enterprises Ltd. (TSXV: NSP) for the production, sale and distribution of Ambarii’s proprietary sublingual full spectrum hemp CBD tablets in Japan and South Korea. Ambarii CBD Tablets offer a consistent, quick dissolving dose of full spectrum hemp oil, combined with the powerful antioxidant properties of pterostilbene.

Lexaria Bioscience Corp., formerly Lexaria Corp., is a food sciences company. The company focuses on the delivery of cannabinoid compounds procured from legal, agricultural hemp, through gourmet foods based upon its infusion technologies. Its food sciences activities include the development of its nutrient infusion technologies for the production of super foods, and the production of food products under its two consumer product brands, ViPova and Lexaria Energy. Its technology is developed to aid absorption and bioavailability of various payload molecules, including cannabinoids, such as cannabidiol (CBD) and tetrahydrocannabinol (THC).

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.